Research ArticleArticle
Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor
José A. Esté, Cecilia Cabrera, Erik De Clercq, Sofie Struyf, Jo Van Damme, Gary Bridger, Renato T. Skerlj, Michael J. Abrams, Geoffrey Henson, Arantxa Gutierrez, Bonaventura Clotet and Dominique Schols
Molecular Pharmacology January 1999, 55 (1) 67-73; DOI: https://doi.org/10.1124/mol.55.1.67
José A. Esté
1
2
3
Cecilia Cabrera
1
2
3
Erik De Clercq
1
2
3
Sofie Struyf
1
2
3
Jo Van Damme
1
2
3
Gary Bridger
1
2
3
Renato T. Skerlj
1
2
3
Michael J. Abrams
1
2
3
Geoffrey Henson
1
2
3
Arantxa Gutierrez
1
2
3
Bonaventura Clotet
1
2
3
Submit a Response to This Article
Jump to comment:
No eLetters have been published for this article.
In this issue
Research ArticleArticle
Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor
José A. Esté, Cecilia Cabrera, Erik De Clercq, Sofie Struyf, Jo Van Damme, Gary Bridger, Renato T. Skerlj, Michael J. Abrams, Geoffrey Henson, Arantxa Gutierrez, Bonaventura Clotet and Dominique Schols
Molecular Pharmacology January 1, 1999, 55 (1) 67-73; DOI: https://doi.org/10.1124/mol.55.1.67
Research ArticleArticle
Activity of Different Bicyclam Derivatives against Human Immunodeficiency Virus Depends on Their Interaction with the CXCR4 Chemokine Receptor
José A. Esté, Cecilia Cabrera, Erik De Clercq, Sofie Struyf, Jo Van Damme, Gary Bridger, Renato T. Skerlj, Michael J. Abrams, Geoffrey Henson, Arantxa Gutierrez, Bonaventura Clotet and Dominique Schols
Molecular Pharmacology January 1, 1999, 55 (1) 67-73; DOI: https://doi.org/10.1124/mol.55.1.67
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement